New Persistent Opioid Use Among ICU Survivors After Discharge: Incidence, Predictors, and Nationwide Cohort Insights

Approximately 4.2% of opioid-naïve ICU survivors develop new persistent opioid use within six months post-discharge.
Early opioid prescription within 30 days of hospital discharge is the strongest predictor of persistence (OR ~20).
Risk profiles differ by opioid potency: potent opioid use is mainly driven by cancer diagnoses, while less-potent opioid use aligns with demographic and socioeconomic factors.
Findings underscore the need for early opioid tapering strategies, multimodal analgesia, and tailored stewardship programs for ICU survivors.

Specialty calculators

For clinical reference; use professional judgment.